The differentiation of avian skeletal muscle in culture: changes in responsiveness of adenylyl cyclase to prostaglandin E1 and adrenergic agonists
- PMID: 2858489
- DOI: 10.1002/jcp.1041230211
The differentiation of avian skeletal muscle in culture: changes in responsiveness of adenylyl cyclase to prostaglandin E1 and adrenergic agonists
Abstract
The responsiveness of adenylyl cyclase during avian myogenesis in vitro has been examined. Measurements of cyclic AMP generation in intact cells revealed that the precursor myoblast is highly responsive to prostaglandin E1 (11-fold maximum stimulation); whereas its response to isoproterenol is much smaller (2-fold). From the onset of terminal differentiation, responsiveness to the beta-adrenergic agonist increases progressively, reaching a 5.5-fold maximum response by 96 hr of culture. In contrast, there is little change in the cell population's responsiveness to prostaglandin E1. The rise in catecholamine responsiveness is consistent with previously reported increases in beta-receptors accompanying differentiation. DL-propranolol blocks the response of myoblasts and myotubes to 10(-6) M isoproterenol with the same half maximal inhibition value of 1 X 10(-8) mol. The results also suggest a change in the adrenergic character of the receptors and/or coupling to adenylyl cyclase as myoblasts differentiate. First the alpha-adrenergic antagonist phentolamine (10(-7)-10(-4) mol) inhibits the myoblast's response but enhances that of the myotube. Second, the potency ratios for the responses to isoproterenol, epinephrine, and norepinephrine shift from 1.1:1.0:1.0 in the myoblast to 3.3:2.1:1.0 in the myotube. The findings are discussed with reference to the role of prostaglandins in the positive control of muscle differentiation and the changes in the catecholamine-responsive adenylyl cyclase system as an aspect of the expression of the muscle phenotype.
Similar articles
-
Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.Mol Pharmacol. 1984 Mar;25(2):256-60. Mol Pharmacol. 1984. PMID: 6321948
-
Regulation of adenylate cyclase coupled beta-adrenergic receptors by beta-adrenergic catecholamines.Endocrinology. 1976 Aug;99(2):347-57. doi: 10.1210/endo-99-2-347. Endocrinology. 1976. PMID: 954636
-
Effects of cholinergic and adrenergic agonists on adenylate cyclase activity of retinal microvascular pericytes in culture.Invest Ophthalmol Vis Sci. 1992 Jan;33(1):42-7. Invest Ophthalmol Vis Sci. 1992. PMID: 1346126
-
Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.Mol Pharmacol. 1984 Sep;26(2):206-13. Mol Pharmacol. 1984. PMID: 6207420
-
Forskolin modulates cyclic AMP generation in the rat myometrium. Interactions with isoproterenol and prostaglandins E2 and I2.J Cyclic Nucleotide Protein Phosphor Res. 1985;10(3):213-27. J Cyclic Nucleotide Protein Phosphor Res. 1985. PMID: 2991348 Review.
Cited by
-
beta-adrenergic receptor population is up-regulated by increased cyclic adenosine monophosphate concentration in chicken skeletal muscle cells in culture.In Vitro Cell Dev Biol Anim. 2000 Jul-Aug;36(7):485-92. doi: 10.1290/1071-2690(2000)036<0485:arpiur>2.0.co;2. In Vitro Cell Dev Biol Anim. 2000. PMID: 11039498
-
Myoblast fusion is regulated by a prostanoid of the one series independently of a rise in cyclic AMP.J Cell Biol. 1986 Sep;103(3):857-66. doi: 10.1083/jcb.103.3.857. J Cell Biol. 1986. PMID: 3017999 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources